CNBC
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
EconomyDaily Composite
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
C
Source
CNBC
Read full article at CNBC
Opens original article in a new tab
Advertisement
